Company
Amgen Inc
NASDAQ:AMGN
Amgen Inc is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology.
45 stories
Nasdaq ends four-day rally as Wall Street takes a breather
SpaceX wiped about $170 billion from its market value following its first results since listing
Salesforce stock rallies as it prepares to join Dow Jones
Salesforce, Amgen and Honeywell all advanced ahead of the Dow reshuffle later this month.
Imugene appoints global pharmaceutical executive to its board
Dr. Lesley Russell brings extensive pharmaceutical experience to the board including a number of cancer therapy collaborations with Teva Pharmaceuticals.
Provention Bio rises after saying Phase 3 study for diabetes drug candidate to begin in 2Q
The biopharmaceutical company says it has entered into an agreement with a clinical research organization to conduct a study of PRV-031
Investments and investor services
EARLY MOVERS: Entera Bio shares soar on collaboration deal with Amgen
CalAmp shares slump due to supply disruptions in moving supply chain out of China
AstraZeneca’s severe asthma treatment granted breakthrough therapy designation
A breakthrough therapy designation is designed to expedite the development and review of medicines that are intended to treat a serious and have shown promise in early-stage clinical trials
Amgen beats 2Q estimates and raises full-year forecast, vows to not hike drug prices again this year
The drugmaker said it would not raise prices this year; Pfizer and Novartis have made similar promises
Amgen Inc. beats the Street boosted by new drug sales
The biotech firm beat analyst expectations on profit and revenue
Amgen shares slip as biotech behemoth misses fourth quarter expectations
The latest results were impacted by a US$6.1bn charge related to the new US tax laws
Buffalo Wild Wings, Amgen Inc and Las Vegas Sands Corp - AFTER HOURS
A look at the risers and fallers after-hours in New York trade
Pfizer, Amgen , Clovis Oncology and more - PRE-MARKET
A look at what stocks are moving the needle, up and down, before the bell in New York
Amgen shares fall as it reveals new cardiovascular risks for its Evenity osteoporosis drug
It said the data showed Evenity having an imbalance in serious cardiovascular adverse events as compared with the current standard of care in osteoporosis, alendronate
US stocks end flat to softer as Fed effect fizzles out
US stocks closed Friday flat to softer as mid-week euphoria over a rate hike fizzled out, and so did the so-called Trump rally
US stocks give back early gains to close lower on healthcare scare
US equities fell on Thursday, as initially buoyant stocks came off on the back of falls by utilities and a budgetary shock for the healthcare sector
Amgen up after judge rules rivals must pull a competing cholesterol drug off the market
District Judge Sue Robinson in Delaware announced a ban on Regeneron and Sanofi from selling their cholesterol drug, Praluent on the grounds of patent infringement.
US stocks clinch record highs, Dow skids (just) shy of 20,000 after jobs report
US stocks clinched fresh record highs on Friday, with the Dow coming within a hair’s breadth of 20,000 – which can only have been helped by Goldman Sach’s shares driving 1.5% higher
Radius Health shares rise 10% on continued bid rumours
Radius Health Inc shares were 10% higher on Friday on continued bid rumours
Unilife licensing gives shares a boost
Unilife announces a strategic collaboration with Amgen
Radius soars as Amgen sees mixed results for osteoporosis drug
Amgen's new osteoporosis treatment may not be as effective as a rival drug being developed by Radius.
Amgen pleased with Phase III anemia trial results
Anemia is a condition in which there is a deficiency of red cells or of haemoglobin in the blood, resulting in tiredness and a lack of energy.
Unilife soars on licensing deal with Amgen
Other interested parties have been told they are out of luck after Unilife decided on Amgen as its partner
Markets off to worst start to a year since 2001
Marine shipping companies got it in the neck but energy companies bucked the trend
Wall Street shares forge ahead after Yellen comments
At the time of writing, the benchmark Dow Jones was up 170 points to 16,371, the Nasdaq gained 32 to 4,765 and the S&P500 added 14 to 1,946.
Archive
Wall Street shares start higher as traders get a break from China
As expected, US shares opened positively as traders welcomed the fact China markets were closed...
AstraZeneca licenses psoriasis rights to Valeant
After Amgen, the originator of the skin condition treatment, abandoned brodalumab, Astra has called on the Canadian dermatology specialist to develop the drug.
Wall Street fell as weak earnings nudge down energy producers; Exxon, Chevron drop
Wall Street was trading lower today as a drop in energy companies' stocks overpowered expectations the U.S. Federal Reserve may delay an interest-rate hike this year following weak wage data. The S&P 500 (INDEXSP:.INX) fell 0.2 percent
Wall Street drops amid Greece debt saga; energy shares slump
U.S. stocks declined as energy stocks dropped with oil and financial shares fell from a seven-year high and as investors eyed the Greece debt saga. The S&P 500 (INDEXSP:.INX) fell 0.4 percent to 2,112.21 at 3:38 p.m. in New York. The 30
U.S. index-futures rise as investors brush aside Greece concerns; ConAgra gains
U.S. stock-index futures were slightly higher today, as U.S. equity investors brushed aside Greece concerns amid optimism the Federal Reserve will continue to shore up the economy. Futures for the Dow Jones Industrial Average inched up 24 p
Wall Street trade higher as investors cheer retail sales; Amgen, Krispy Kreme gain
Wall Street was trading higher before the close of trading today on optimism Greece would approve an aid-for-reforms deal and amid strong U.S. retail sales, which lifted the U.S. dollar and raised bets the Federal Reserve will raise interes
U.S. stock-index futures waver as investors assess retail sales, jobless claims
Futures for the Dow Jones Industrial Average were up 8 points to 18,025, while those for the S&P 500 index about flat at 2,106.70. Meanwhile, futures for the Nasdaq-100 Index were trading flat to a whisker higher at 4,490.75. U.S. stock